carbostyril has been researched along with Infections, Helicobacter in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (11.11) | 18.2507 |
| 2000's | 34 (41.98) | 29.6817 |
| 2010's | 31 (38.27) | 24.3611 |
| 2020's | 7 (8.64) | 2.80 |
| Authors | Studies |
|---|---|
| Areia, M; Barrio, J; Beglinger, C; Bordin, D; Boyanova, L; Bujanda, L; Buzas, GM; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernandez, M; Doulberis, M; Fernandez-Salazar, L; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Jurecic, NB; Kunovský, L; Kupčinskas, J; Lamy, V; Lanas, A; Lasala, JP; Leja, M; Lerang, F; Lucendo, AJ; Marcos-Pinto, R; Marlicz, W; Megraud, F; Milivojevic, V; Molina-Infante, J; Morain, CO; Niv, Y; Nyssen, OP; Ortuño, J; Pérez Aísa, Á; Phull, P; Puig, I; Rodrigo, L; Rokkas, T; Sarsenbaeva, AS; Shvets, O; Simsek, I; Smith, S; Tepes, B; Tonkić, A; Vaira, D; Venerito, M; Vologzhanina, L; Voynovan, I | 1 |
| Niu, Z; Ren, X; Song, Z; Suo, B; Tian, X; Xue, Y; Zhou, L | 1 |
| Babic, I; Gisbert, J; Kekic, D; Krstic, M; Mégraud, F; Milivojevic, V; Milosavljevic, T; Moreira, L; Nyssen, OP; O' Morain, C; Panic, N; Rankovic, I; Sagdati, S; Spasic, IS | 1 |
| Desai, T; Edhi, AI; Hakim, S | 1 |
| Chang, YL; Hsu, PI; Kim, SE; Liou, WS; Shiu, SI; Tu, YK; Tung, YC; Wu, MF; Yang, JC; Yeh, HZ | 1 |
| Cao, M; Chen, H; Cram, DS; Liu, X; Lv, N; Lv, T; Wang, H; Xie, Y; Zhang, C; Zhong, J; Zhou, L | 1 |
| Andreev, DN; Maev, IV | 1 |
| Bae, HI; Jeon, SW; Kwon, YH; Lee, HS; Lee, JS; Nam, SY; Seo, AN | 1 |
| Gisbert, JP; Marin, AC; McNicholl, AG; Nyssen, OP | 1 |
| Bilgilier, C; Biowski-Frotz, S; Blesl, A; Datz, C; Effenberger, M; Gombotz, G; Graziadei, I; Hinterberger, I; Hirschl, AM; Högenauer, C; Huber-Schönauer, U; Hubmann, R; Kastner, MT; Klimpel, S; Knoflach, P; Kundi, M; Leiner, J; Ludwiczek, O; Makristathis, A; Mitrovits, N; Moser, M; Püspök, A; Schöfl, R; Schöniger-Hekele, M; Schrutka-Kölbl, C; Siebert, F; Stadlmann, A; Steiner, P; Steininger, C; Stupnicki, T; Thannesberger, J; Tilg, H; Watzinger, N; Wewalka, F; Wurzer, H | 1 |
| Mori, H; Suzuki, H | 1 |
| Abe, H; Adachi, H; Amalia, E; Hayashi, C; Igarashi, M; Inaoka, DK; Kawada, M; Kita, K; Masuda, T; Mimuro, H; Mochizuki, K; Ohba, SI; Ohishi, T; Shibasaki, M; Watanabe, T | 1 |
| Chung, JW; Kim, J; Kim, K; Kim, KO; Kim, SY; Kim, YJ; Kwon, KA; Lee, JS; Park, DK | 1 |
| An, Y; Fu, YJ; Li, Z; Qian, X; Wang, Y; Wang, YH; Wu, S; Xie, Y | 1 |
| Ho, HJ; Hsu, CC; Lee, CC; Lin, JT; Liou, JM; Wu, CY; Wu, MS; Yeo, YH | 1 |
| Andreev, DN; Dicheva, DT; Maev, IV; Partzvania-Vinogradova, EV; Samsonov, AA | 1 |
| Furuta, T; Handa, O; Kato, M; Kikuchi, S; Mabe, K; Murakami, K; Okuda, M; Ota, H; Satoh, K; Shimoyama, T; Sugiyama, T; Suzuki, H; Takahashi, S; Uemura, N | 1 |
| Jaka, H; Kasang, C; Mshana, SE; Mueller, A | 1 |
| de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J | 1 |
| Glocker, EO; Kist, M; Stueger, HP; Wueppenhorst, N | 1 |
| Bazzoli, F; Calvet, X; Fallone, C; Fischbach, L; Ford, AC; Forman, D; Gisbert, JP; Khan, KJ; Leontiadis, GI; Moayyedi, P; Oderda, G; Tse, F; Yuan, Y | 1 |
| Kim, N; Lee, JY | 1 |
| Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S | 1 |
| Chuah, SK; Hu, TH; Lee, CH; Liang, CM; Tai, WC | 1 |
| Kanai, T; Nishizawa, T; Nishizawa, Y; Suzuki, H; Takahashi, M; Yahagi, N | 1 |
| Fischbach, W; Glocker, E; Malfertheiner, P; Scherübl, H | 1 |
| Akiyama, T; Haruma, K; Hata, J; Inoue, K; Ito, M; Kamada, T; Manabe, N; Matsumoto, H; Murao, T; Sato, M; Shiotani, A; Tanaka, S; Tokutomi, T; Watanabe, T | 1 |
| Chen, X; Han, X; Jiang, K; Li, S; Wang, B; Zhou, L | 1 |
| Chao, CY; Che, YJ; Kao, CY; Lee, GB; Wang, CH; Wu, JJ | 1 |
| Choi, KY; Hwang, WC; Kang, DW; Min, do S; Noh, YN | 1 |
| Ichikawa, T; Iijima, K; Koike, T; Ogawa, M; Ohara, S; Okada, S; Shimosegawa, T | 1 |
| Hibi, T; Iwasaki, E; Masaoka, T; Minegishi, Y; Nakagawa, I; Nishizawa, T; Suzuki, H | 1 |
| Chayanupatkul, M; Klaikeaw, N; Mahachai, V; Rerknimitr, R; Thong-Ngam, D | 1 |
| Furuta, T | 1 |
| Naito, Y; Yoshikawa, T | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Higuchi, W; Kanda, H; Takano, T; Yamamoto, T | 1 |
| Furuta, T; Kodaira, C; Nishino, M; Sugimoto, M; Uotani, T; Yamade, M | 1 |
| Bo, J; Chen, MH; Fan, DM; Ge, ZZ; Ji, F; Jung, HC; Kim, JH; Lee, SW; Lee, YC; Song, KH | 1 |
| Bornschein, J; Malfertheiner, P; Selgrad, M | 1 |
| Chang, WL; Cheng, HC; Huang, AH; Kao, CY; Sheu, BS; Wu, CT; Wu, JJ; Yang, HB | 1 |
| Chin, YW; Chung, YH; Jung, K; Kim, J; Lee, B; Min, DS; Park, YH; Yoo, H | 1 |
| Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Tanigawa, T; Tominaga, K; Wada, R; Watanabe, T | 1 |
| Haga, K; Hirayama, F; Iwao, E; Takagi, S; Yamamoto, K; Yokoyama, Y | 1 |
| Adachi, K; Fujishiro, H; Kinoshita, Y; Komazawa, Y; Mihara, T | 1 |
| Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM | 1 |
| Bello, A; Christopher, L; Gajjar, DA; Ge, Z; Grasela, DM | 1 |
| Genta, RM | 1 |
| Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Oshitani, N; Sasaki, E; Shiba, M; Takashima, T; Tanigawa, T; Tominaga, K; Watanabe, T | 1 |
| Cho, SW; Cho, YK; Hahm, KB; Joo, HJ; Kim, DH; Kim, JH; Kim, YB; Lee, JS; Lee, KM; Nam, KT; Surh, YJ; Yoo, BM | 1 |
| Akiba, Y; Ishii, H; Matsui, H; Nakamura, M; Tsuchimoto, K | 1 |
| Arakawa, T; Asaka, M; Fujioka, T; Ishii, H; Itoh, M; Kawai, S; Kobayashi, K; Kuwayama, H; Sato, R; Shimoyama, T; Takemoto, T; Yoshikawa, T | 1 |
| Bevilacqua, C; Gaboriau-Routhiau, V; Heyman, M; Matysiak-Budnik, T; Mayo, K; Mégraud, F; Moreau, MC; van Niel, G | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Tominaga, K; Watanabe, T | 1 |
| Arakawa, T; Fujiwara, Y; Hamasaki, N; Higuchi, K; Ishii, E; Kadota, S; Nagaoka, T; Oshitani, N; Sasaki, E; Tanigawa, T; Tezuka, Y; Tominaga, K; Watanabe, T | 1 |
| Arakawa, T; Asaka, M; Fujioka, T; Haruma, K; Ishii, H; Kinoshita, Y; Kobayashi, K; Sakaki, N; Sakamoto, C; Shimosegawa, T; Sugiyama, T; Takahashi, S; Terano, A; Yoshikawa, T | 1 |
| Glocker, E; Kist, M; Stueger, HP | 1 |
| Asencio, C; Candalh, C; Heyman, M; Laharie, D; Matysiak-Budnik, T; Mégraud, F; Ménard, S; Rullier, A; Vidal-Martinez, T; Zerbib, F | 1 |
| Fukui, H; Takakura, Y; Yajima, H; Yamao, J | 1 |
| Arakawa, T; Haruma, K; Higuchi, K; Joh, T; Kobayashi, K; Murakami, K; Sugiyama, T; Suzuki, H; Terano, A; Yoshikawa, T | 1 |
| Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Chen, J; Du, Y; Fang, D; Gao, J; Gong, Y; Guo, X; He, L; Jiang, B; Li, Y; Li, Z; Ren, J; Shi, R; Tian, Z; Wu, J; Zhan, X; Zhang, Z | 1 |
| Chitapanarux, T; Lertprasertsuke, N; Praisontarangkul, OA | 1 |
| Cho, SW; Hahm, KB; Joo, HJ; Kim, JH; Kim, YS; Lee, KJ; Yim, H | 2 |
| Cho, SW; Chung, MH; Hahm, KB; Kim, JH; Lee, KJ | 1 |
| Ando, K; Arakawa, T; Fujiwara, Y; Fukuda, T; Higuchi, K; Kobayashi, K; Kuroki, T; Nebiki, H; Takaishi, O; Uchida, T; Yamasaki, K | 1 |
| Ishii, H; Kai, A; Miura, S; Mori, M; Suematsu, M; Suzuki, H; Suzuki, M | 1 |
| Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H | 1 |
| Ando, K; Arakawa, T; Harihara, S; Higuchi, K; Ito, H; Kobayashi, K; Kuroki, T; Nebiki, H; Uchida, T | 1 |
| Hirayama, F; Ikeda, Y; Kawakita, T; Kuroda, T; Moriguchi, A; Sakurai, N; Sano, M; Uemori, S; Yamamoto, K | 1 |
| Abely, M; de Mascarel, A; Heyman, M; Matysiak-Budnik, T; Mayo, K; Mégraud, F | 1 |
| Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T | 1 |
| Masamune, A; Sakai, Y; Shimosegawa, T; Yoshida, M | 1 |
| Heyman, M; Matysiak-Budnik, T; Mégraud, F; Thomas-Collignon, A | 1 |
| Marcuard, SP; Riff, DS; Schwartz, H; Talley, NJ | 1 |
| Inaba, T; Kawai, K; Kita, K; Mizuno, M; Okada, H; Takaguchi, K; Tsuji, T; Yoshida, Y | 1 |
| Choi, KW; Choi, MG; Chung, IS; Chung, MH; Hahm, KB; Hong, WS; Jung, HY; Kim, JG; Kim, JH; Kim, NY; Kim, SW; Lee, JJ; Lee, SW; Lee, YC; Roe, IH | 1 |
| Fukuda, S; Liu, Q; Shimoyama, T; Sugawara, K | 1 |
| Chayama, K; Haruma, K; Ito, M; Kido, S; Kitadai, Y; Manabe, N; Sumii, M; Tanaka, S; Yoshihara, M | 1 |
| Burette, A; Glupczynski, Y | 1 |
19 review(s) available for carbostyril and Infections, Helicobacter
| Article | Year |
|---|---|
Efficacy of second-line regimens for
Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Outcome Assessment, Health Care; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Tetracycline | 2020 |
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones | 2017 |
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; Gastritis; Health Planning Guidelines; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Japan; Metronidazole; National Health Programs; Quinolones; Rifabutin; Stomach Neoplasms | 2018 |
Fourth-generation quinolones in the treatment of
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Microbial Sensitivity Tests; Proton Pump Inhibitors; Quinolones; Treatment Outcome | 2018 |
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Comparative Effectiveness Research; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Network Meta-Analysis; Quinolones; Randomized Controlled Trials as Topic; Retreatment | 2019 |
Optimum duration of regimens for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Quinolones | 2013 |
[Future trends of Helicobacter pylori eradication therapy in Korea].
Topics: Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Republic of Korea; Treatment Failure | 2014 |
Quinolone-containing therapies in the eradication of Helicobacter pylori.
Topics: Disease Eradication; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Tuberculosis | 2014 |
Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
Topics: Alanine; Amoxicillin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Odds Ratio; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
[What is new in treating Helicobacter pylori infection?].
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Quinolones; Stomach Neoplasms | 2015 |
[Present status and future prospect of 3rd rescue regimen for H. pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Quinolones | 2009 |
Guidelines for treatment of Helicobacter pylori in the East and West.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Quinolones; Treatment Outcome; Vaccination | 2011 |
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cytokines; Disease Models, Animal; Helicobacter Infections; Helicobacter pylori; Humans; Methylnitrosourea; Mice; NF-kappa B; Quinolones; Stomach Neoplasms; Sulfonamides | 2003 |
Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract.
Topics: Alanine; Anti-Ulcer Agents; Cells, Cultured; Clinical Trials as Topic; Colitis; Gastritis; Helicobacter Infections; Humans; Models, Biological; Quinolones | 2003 |
[Quality of ulcer healing and rebamipide].
Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Quinolones; Recurrence; Stomach Ulcer; Wound Healing | 2005 |
[Treatment for Helicobacter pylori: current criteria].
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome | 2007 |
Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
Topics: Alanine; Antioxidants; Apoptosis; DNA Damage; Helicobacter Infections; Helicobacter pylori; Humans; Oxidative Stress; Quinolones; Stomach Neoplasms | 1998 |
[Rebamipide].
Topics: Alanine; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation Mediators; Neutrophil Activation; Oxidative Stress; Peptic Ulcer; Quinolones; Urease | 2002 |
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Nitroimidazoles; Quinolones | 1990 |
25 trial(s) available for carbostyril and Infections, Helicobacter
| Article | Year |
|---|---|
Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Metronidazole; Proton Pump Inhibitors; Quinolones; Treatment Outcome | 2023 |
Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
Topics: Alanine; Atrophy; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Pilot Projects; Prospective Studies; Quinolones; Stomach Neoplasms | 2022 |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Topics: Adult; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Prospective Studies; Quinolones; Treatment Outcome | 2018 |
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinolones; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome | 2015 |
Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Quinolones; Stomach | 2015 |
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Homeodomain Proteins; Humans; Male; Metaplasia; Middle Aged; Peptides; Precancerous Conditions; Quinolones; Stomach Neoplasms; Trefoil Factor-3 | 2015 |
Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Stomach Ulcer; Treatment Outcome | 2009 |
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Quinolones; Stomach Ulcer; Treatment Outcome; Wound Healing; Young Adult | 2011 |
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Anti-Ulcer Agents; Breath Tests; False Negative Reactions; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Piperidines; Predictive Value of Tests; Quinolones; Urea | 2003 |
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
Topics: Administration, Oral; Adult; Electrocardiography; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Indoles; Placebos; Psychometrics; Quinolones | 2003 |
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Stomach Ulcer | 2003 |
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Pilot Projects; Quinolones; Stomach Ulcer; Treatment Outcome | 2006 |
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Prevalence; Proton Pump Inhibitors; Quinolones; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2007 |
Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.
Topics: Adult; Alanine; Anti-Inflammatory Agents; Anti-Ulcer Agents; China; Dinoprostone; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Malondialdehyde; Middle Aged; Quinolones; Sucralfate | 2008 |
An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.
Topics: Adult; Alanine; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Endoscopy, Gastrointestinal; Endpoint Determination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Quinolones; Thailand; Young Adult | 2008 |
Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chemokines; Cytokines; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Humans; Lansoprazole; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Quinolones | 1998 |
Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
Topics: Aged; Alanine; Anti-Ulcer Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Recurrence; Stomach Ulcer; Treatment Outcome | 1998 |
Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori.
Topics: Adult; Aged; Alanine; Antioxidants; Apoptosis; Catalase; Cytokines; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Glutathione Peroxidase; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinolones; Reactive Oxygen Species; Superoxide Dismutase; Treatment Outcome | 1998 |
Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Quinolones; Stomach Ulcer; Treatment Outcome | 1998 |
Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Topics: Adult; Aged; Alanine; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Quinolones; Stomach Ulcer; Treatment Outcome | 1998 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Quinolones; Stomach; Time Factors | 2000 |
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
Topics: Abdominal Pain; Adult; Alanine; Antacids; Anti-Ulcer Agents; Double-Blind Method; Dyspepsia; Eructation; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Treatment Outcome | 2001 |
[Effect of antiulcer agents on the urea breath test--Comparison between rebamipide and ecabet sodium].
Topics: Abietanes; Alanine; Anti-Ulcer Agents; Breath Tests; Diterpenes; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Predictive Value of Tests; Quinolones; Urea | 2002 |
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage.
Topics: Adult; Alanine; Antioxidants; Chemokine CCL5; Cytokines; Drug Therapy, Combination; Duodenal Ulcer; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-1; Interleukin-8; Male; Quinolones; Tumor Necrosis Factor-alpha; Tyrosine | 2002 |
Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis.
Topics: Alanine; Anti-Ulcer Agents; Drug Administration Schedule; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pepsinogens; Quinolones; Stomach | 2002 |
37 other study(ies) available for carbostyril and Infections, Helicobacter
| Article | Year |
|---|---|
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Penicillins; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Tetracycline | 2022 |
Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Serbia; Tetracycline; Treatment Outcome | 2023 |
Eradicating H. pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States | 2019 |
Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study.
Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; RNA, Bacterial; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S | 2021 |
[Rebamipide: evidence base for use in gastroenterology].
Topics: Alanine; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones | 2020 |
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Austria; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Genes, Bacterial; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Histocytochemistry; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Real-Time Polymerase Chain Reaction; Young Adult | 2018 |
Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Treatment Outcome | 2018 |
[The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
Topics: Abietanes; Adult; Aged; Alanine; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Proton Pump Inhibitors; Quinolones; Retrospective Studies; Treatment Outcome | 2018 |
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Practice Guidelines as Topic; Quinolones; Young Adult | 2019 |
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Quinolones; Tanzania; Tertiary Care Centers; Treatment Failure; Young Adult | 2019 |
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult | 2019 |
High secondary resistance to quinolones in German Helicobacter pylori clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Quinolones | 2013 |
An integrated microfluidic system for diagnosis of the resistance of Helicobacter pylori to quinolone-based antibiotics.
Topics: Biosensing Techniques; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Microfluidics; Polymorphism, Single Nucleotide; Quinolones | 2016 |
Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Topics: Alanine; Animals; Anticarcinogenic Agents; Antigens, Bacterial; Apoptosis; Bacterial Proteins; beta Catenin; Cell Line, Tumor; Cell Self Renewal; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Nick-End Labeling; Mice, SCID; Quinolones; Signal Transduction; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.
Topics: Adult; Alanine; Anti-Ulcer Agents; Chromatography, Ion Exchange; Endoscopy, Gastrointestinal; Female; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mucins; Quinolones | 2009 |
Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.
Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Gerbillinae; Hedgehog Proteins; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones | 2009 |
Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Alendronate; Allopurinol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Interactions; Gastritis; Helicobacter Infections; Humans; Male; Mice; Quinolones; Randomized Controlled Trials as Topic; Rats; Stomach Ulcer | 2010 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
In vitro activity of DX-619, a des-F(6)-quinolone, against Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Pyrrolidines; Quinolones; Young Adult | 2011 |
Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan.
Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Breath Tests; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Patient Selection; Phenotype; Predictive Value of Tests; Quinolones; Ribotyping; Stomach; Treatment Failure | 2011 |
Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Naphthyridines; Quinolones; Taiwan | 2012 |
Anti-gastritis and wound healing effects of Momordicae Semen extract and its active component.
Topics: Alanine; Animals; Anti-Ulcer Agents; Calcitonin Gene-Related Peptide; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Male; Mice; Momordica; Plant Extracts; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; Saponins; Seeds; Skin; Wound Healing | 2013 |
Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Topics: Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Cell Division; Epithelium; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Neutrophil Infiltration; Quinolones; Stomach Ulcer; Wound Healing | 2002 |
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Quinolones | 2002 |
Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.
Topics: Alanine; Animals; Anti-Ulcer Agents; Chemokines; Cimetidine; Gastrins; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Neutrophils; Peroxidase; Quinolones; Tumor Necrosis Factor-alpha | 2003 |
Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
Topics: Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Cytokines; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Immunohistochemistry; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; NF-kappa B; Protein Binding; Proteins; Quinolones; RNA, Messenger | 2003 |
Interaction of leptin with gastric myofibroblast transdifferentiation in Helicobacter pylori-infected Mongolian gerbils: the effect of rebamipide.
Topics: Alanine; Animals; Anti-Ulcer Agents; Autoradiography; Cell Differentiation; Fibroblasts; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Immunohistochemistry; Leptin; Quinolones | 2003 |
Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.
Topics: Administration, Oral; Alanine; Anaphylaxis; Animals; Antigen Presentation; Antigens; Chickens; Female; Gastritis; Helicobacter Infections; Immune Tolerance; Immunity, Mucosal; Immunoglobulin E; Immunoglobulin G; In Vitro Techniques; Intestines; Mice; Mice, Inbred C3H; Muramidase; Ovalbumin; Quinolones; T-Lymphocytes | 2003 |
[Antibacterial activity of a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori].
Topics: Alkaloids; Animals; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Chinese Herbal; Evodia; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Plant Extracts; Quinolines; Quinolones | 2005 |
Quinolone resistance in Helicobacter pylori isolates in Germany.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Quinolones | 2007 |
Effect of rebamipide on the colonic barrier in interleukin-10-deficient mice.
Topics: Alanine; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Female; Flow Cytometry; Helicobacter hepaticus; Helicobacter Infections; Interleukin-10; Intestinal Mucosa; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Quinolones; Specific Pathogen-Free Organisms; T-Lymphocytes | 2007 |
Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Bone Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Endoscopy; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Life Style; Male; Middle Aged; Outpatients; Peptic Ulcer; Prospective Studies; Quinolones; Risk Factors | 2007 |
Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Quinolones; Stomach Ulcer | 1998 |
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Stability; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Ofloxacin; Quinolones; Solutions; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis.
Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Helicobacter; Helicobacter Infections; Mice; Mice, Inbred C57BL; Permeability; Quinolones | 2000 |
Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; Blotting, Western; Ceramides; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Mitogen-Activated Protein Kinases; NF-kappa B; Quinolones; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2001 |
Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
Topics: Alanine; Anti-Ulcer Agents; Cell Membrane Permeability; Epithelial Cells; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interferon-gamma; Interleukin-1; Quinolones; Tumor Cells, Cultured | 2001 |